Organon & Co at Morgan Stanley Global Healthcare Conference (Fireside Chat) Transcript
Thanks for joining us again for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have Organon with us for the next session.
I need to read a quick disclosure statement before we get started. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures are seen on Morgan Stanley public website at morganstanley.com/researchdisclosures.
And very pleased to have from Organon, Kevin Ali, the CEO; and Matt Walsh, the CFO.
Questions & Answers
Kevin, I thought maybe just to start us off, since obviously, people are familiar with the company because of the spin from Merck, but may not be as familiar with the focus of the company and the key products. Maybe we could just take a minute or 2 to walk through what the vision is for the company and how you're thinking about the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
